Abstract
Transformation and metastasis are complex processes that depend on integration of effects from multiple mutations. Modeling this complexity requires manipulating multiple genes in particular sub-populations of cells in vivo. This is technically challenging in mammalian model systems and has limited the rate of progress in understanding the effects of the complex aberrations present in cancer cells. In contrast, powerful genetic methods in the fruit fly Drosophila allow efficient generation and analysis of complex genotypes in defined cell populations. These methods are already fruitful in exploring the interactions among cancer mutations, and between cell populations that mimic the tumor microenvironment. In this issue of Oncogene, Willecke et al. (2011) describe the implementation of a novel genetic screen in Drosophila to identify genes required for tumor growth in vivo. This report illustrates the power of using Drosophila to perform systematic genome-wide genetic screens in complex genetic backgrounds and for the resulting data to inform our understanding of transformation and metastasis in human systems.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6
Scientific Reports Open Access 13 January 2021
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Baker NE . (2007). Patterning signals and proliferation in Drosophila imaginal discs. Curr Opin Genet Dev 17: 287–293.
Bier E . (2005). Drosophila, the golden bug, emerges as a tool for human genetics. Nat Rev Genet 6: 9–23.
Blair SS . (2003). Genetic mosaic techniques for studying Drosophila development. Development 130: 5065–5072.
Brand AH, Perrimon N . (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401–415.
Brumby AM, Richardson HE . (2003). Scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J 22: 5769–5779.
Brumby AM, Richardson HE . (2005). Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer 5: 626–639.
Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M et al. (2007). A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448: 151–156.
Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW et al. (2010). Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999–1005.
Fortini ME, Skupski MP, Boguski MS, Hariharan IK . (2000). A survey of human disease gene counterparts in the Drosophila genome. J Cell Biol 150: F23–F30.
Grewal SS . (2009). Insulin/TOR signaling in growth and homeostasis: a view from the fly world. Int J Biochem Cell Biol 41: 1006–1010.
Halder G, Johnson RL . (2011). Hippo signaling: growth control and beyond. Development 138: 9–22.
Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE . (2008). Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene 27: 6888–6907.
Lee T, Luo L . (1999). Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron 22: 451–-461.
Mummery-Widmer JL, Yamazaki M, Stoeger T, Novatchkova M, Bhalerao S, Chen D et al. (2009). Genome-wide analysis of Notch signalling in Drosophila by transgenic RNAi. Nature 458: 987–992.
Neely GG, Hess A, Costigan M, Keene AC, Goulas S, Langeslag M et al. (2010a). A genome-wide Drosophila screen for heat nociception identifies alpha2delta3 as an evolutionarily conserved pain gene. Cell 143: 628–638.
Neely GG, Kuba K, Cammarato A, Isobe K, Amann S, Zhang L et al. (2010b). A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell 141: 142–153.
Newsome TP, Asling B, Dickson BJ . (2000). Analysis of Drosophila photoreceptor axon guidance in eye-specific mosaics. Development 127: 851–860.
Pagliarini RA, Xu T . (2003). A genetic screen in Drosophila for metastatic behavior. Science 302: 1227–1231.
Pan D . (2010). The hippo signaling pathway in development and cancer. Dev Cell 19: 491–505.
Pospisilik JA, Schramek D, Schnidar H, Cronin SJ, Nehme NT, Zhang X et al. (2010). Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell 140: 148–160.
Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM et al. (2010). Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18: 510–523.
Rubin GM, Yandell MD, Wortman JR, Gabor Miklos GL, Nelson CR, Hariharan IK et al. (2000). Comparative genomics of the eukaryotes. Science 287: 2204–2215.
Schnorrer F, Schonbauer C, Langer CC, Dietzl G, Novatchkova M, Schernhuber K et al. (2010). Systematic genetic analysis of muscle morphogenesis and function in Drosophila. Nature 464: 287–291.
St Johnston D . (2002). The art and design of genetic screens: Drosophila melanogaster. Nat Rev Genet 3: 176–188.
Willecke M, Toggweiler J, Basler K . (2011). Loss of PI3Kinase blocks cell cycle progression in a Drosophila tumor model. Oncogene 30: 4067–4074.
Wu M, Pastor-Pareja JC, Xu T . (2010). Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 463: 545–548.
Xu T, Rubin GM . (1993). Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117: 1223–1237.
Acknowledgements
We thank Leisa McCord for art production.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Halder, G., Mills, G. Drosophila in cancer research: to boldly go where no one has gone before. Oncogene 30, 4063–4066 (2011). https://doi.org/10.1038/onc.2011.128
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.128